Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking estrogen receptors, progesterone receptors and lacks HER2 overexpression. This absence of critical molecular targets poses significant challenges for conventional therapies. Immunotherapy, remarkably immune checkpoint blockade, of...
Saved in:
Main Authors: | Linlin Zhou (Author), Chen-Wei Yu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment
by: Mahsa Keihan Shokooh, et al.
Published: (2021) -
Pan-Cancer Screening and Validation of CALU’s Role in EMT Regulation and Tumor Microenvironment in Triple-Negative Breast Cancer
by: Chen SL, et al.
Published: (2024) -
Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
by: Tong Gao, et al.
Published: (2023) -
Is there an epigenetic component underlying the resistance of triple-negative breast cancers to PARP inhibitors?
by: Amanda eLovato, et al.
Published: (2012) -
Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis
by: Weilun Cheng, et al.
Published: (2024)